Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 436.60
+1.90 (0.44%)
Apr 17, 2026, 3:30 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 173.81 billion as of April 17, 2026. Its market cap has decreased by -38.81% in one year.
Market Cap
173.81B
Enterprise Value
168.72B
Revenue
37.20B
Ranking
n/a
PE Ratio
54.84
Stock Price
436.60
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 173.81B, an increase of 179.84%. That is a compound annual growth rate of 10.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 173.81B | -32.93% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.02T |
| Divi's Laboratories | 1.65T |
| Apollo Hospitals Enterprise | 1.11T |
| Cipla | 1.00T |
| Sagility | 200.97B |
| NATCO Pharma | 200.55B |
| Eris Lifesciences | 200.26B |
| Piramal Pharma | 197.65B |